![Elizabeth Faust](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Faust
Directeur/Membre du Conseil chez
BIOMEA FUSION, INC.
Fortune : - $ au 31/05/2026
Profil
Elizabeth A. Faust is currently Independent Director at Biomea Fusion, Inc. since 2022 and Principal & Owner at Faust Consulting LLC since 2018.
Former roles include Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc. from 2008 to 2010, Vice President-Medical Affairs at Pharmacyclics LLC from 2013 to 2015, Executive Vice President-Medical Affairs at Tricida, Inc. from 2019 to 2020, Vice President-Clinical Research Sciences at Celgene Corp., Vice President-Medical Affairs at Kite Pharma, Inc. from 2016 to 2018, and Vice President-Medical Affairs at Pharmacyclics, Inc. from 2013 to 2015.
Education includes a doctorate from the University of California, Los Angeles, graduate studies at the University of California, Riverside, and undergraduate studies at Auburn University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Elizabeth Faust
| Sociétés | Poste | Début |
|---|---|---|
| BIOMEA FUSION, INC. | Directeur/Membre du Conseil | 01/06/2022 |
Anciens postes connus de Elizabeth Faust
| Sociétés | Poste | Fin |
|---|---|---|
| TRICIDA, INC. | Directeur Technique/Scientifique/R&D | 01/08/2020 |
| CELGENE | Directeur Technique/Scientifique/R&D | 01/11/2019 |
| KITE PHARMA INC | Directeur Technique/Scientifique/R&D | 01/07/2018 |
| PHARMACYCLICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2015 |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Directeur Technique/Scientifique/R&D | 01/11/2015 |
Formation de Elizabeth Faust
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auburn University
 Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Biomea Fusion, Inc.
 Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Health Technology |
